Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 9:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 3,123 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neurobehavioral Manifestation Clear all

Conditions: Mucopolysaccharidosis II
Interventions: Observational; Other
Lead sponsor: REGENXBIO Inc.; Industry
Eligibility: 1 Month to 8 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Oakland, California • Philadelphia, Pennsylvania

Conditions: Nail Diseases, Nail Abnormality
Interventions: Hydrocodone 5Mg/Acetaminophen 325Mg Tab, Acetaminophen 1000mg, Ibuprofen 400 mg; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 95 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Maternal Depression
Interventions: Project Solve Education; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: Female only
Enrollment: 188 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 4
States / cities: Boston, Massachusetts • Natick, Massachusetts • Quincy, Massachusetts + 1 more

Conditions: Hip Fractures (ICD-10 72.01-72.2), Post Operative Analgesia
Interventions: Suzetrigine (Journavx); Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: tACS (alpha), tDCS; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 70 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Anhedonia, Depression
Interventions: Carbidopa Levodopa, Placebo; Drug
Lead sponsor: Emory University; Other
Eligibility: 25 Years to 55 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Down Syndrome, Cognitive Dysfunction
Interventions: Aricept (donepezil hydrochloride), Placebo; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 11 Years to 17 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 2
States / cities: San Antonio, Texas • Herndon, Virginia

Conditions: Delirium, Sleep Disturbance
Interventions: Nighttime Vital Sign EHR Alert, No EHR alert; Behavioral · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: Not listed
Enrollment: 1,436 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Intellectual Disability, Autism Spectrum Disorder, Self-Injurious Behavior, Communication Disabilities, Communication, Nonverbal
Interventions: PrefFCT, NonPrefFCT; Behavioral
Lead sponsor: Joel E. Ringdahl; Other
Eligibility: 2 Years to 90 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 2
States / cities: Athens, Georgia • Iowa City, Iowa

Conditions: Pain
Interventions: St. John's Wort, oxycodone, fentanyl; Drug
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 21 Years to 45 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Postural Orthostatic Tachycardia Syndrome, Syncope, Vasovagal, Neurocardiogenic Syncope
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 10 Years to 21 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Aging, Memory Loss
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: 50 Years and older
Enrollment: 340 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Alzheimer Disease, Agitation in Dementia
Interventions: hMSC; Biological
Lead sponsor: Bernard (Barry) Baumel; Other
Eligibility: 55 Years to 90 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Fragile x Syndrome
Interventions: Ganaxolone, Placebo; Drug
Lead sponsor: Marinus Pharmaceuticals; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Opioid Use, Pain, Postoperative
Interventions: Educational handout instrument, Control; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Aphasia, Stroke
Interventions: Anodal transcranial direct current stimulation, Sham transcranial direct current stimulation, Speech-language therapy; Device · Behavioral
Lead sponsor: Louisiana State University and A&M College; Other
Eligibility: 18 Years to 85 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Advanced Cancer, Pain
Interventions: I-STAMP; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 21 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Developmental Language Disorder, Speech Sound Disorder, Specific Language Impairment
Interventions: Sensitivity to phonological rules & referents OR: Toddlers, Sensitivity to phonological rules & referents FR: Toddlers; Other
Lead sponsor: Father Flanagan's Boys' Home; Other
Eligibility: 19 Months to 36 Months
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Alzheimer Disease, Dementia, Dementia, Vascular, Pain
Interventions: hydrocodone/APAP w placebo PRN, hydrocodone/APAP, placebo with hydrocodone/APAP PRN; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 55 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 3
States / cities: Tuscaloosa, Alabama

Conditions: Developmental Language Disorders
Interventions: Grammar Treatment; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 8 Years to 11 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 4
States / cities: Tucson, Arizona • Athens, Ohio • Logan, Utah + 1 more

Conditions: Cardiac Arrest, Out-Of-Hospital, Hypothermia, Induced, Hypoxia-Ischemia, Brain
Interventions: Therapeutic Hypothermia; Device
Lead sponsor: University of Michigan; Other
Eligibility: 2 Days to 17 Years
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 52
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 44 more

Conditions: Lung Cancer
Interventions: Questionnaire, Telephone Interactive System, Blood Samples; Behavioral · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2010
U.S. locations: 4
States / cities: Miami, Florida • Houston, Texas

Conditions: Rett Syndrome
Interventions: fenfluramine hydrochloride, Placebo; Drug · Other
Lead sponsor: UCB BIOSCIENCES, Inc.; Industry
Eligibility: 5 Years to 35 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 8
States / cities: Little Rock, Arkansas • Miami, Florida • Orlando, Florida + 5 more

Conditions: Rib Fractures
Interventions: hydromorphone hydrochloride, Infusion catheter placement, bupivicaine 0.25%, bupivicaine 0.5%; Drug · Procedure
Lead sponsor: Anthony Iacco; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Royal Oak, Michigan

Search by objective public record fields.

Mucopolysaccharidosis Type II Observational

Hydrocodone Compared to Acetaminophen and Ibuprofen for Post-nail Procedure Analgesia

Reducing Risk After an Adverse Pregnancy Outcome

Suzetrigine (Journavx) as Multimodal Therapy for Pain Management in Adults Undergoing Surgery for Hip Fracture

STimulation to Improve Auditory haLLucinations

Dopaminergic Therapy for Anhedonia - 2

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17

De-escalating Vital Sign Checks

Harnessing Communication Preferences

Herb-Opioid Interactions

Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects

Couples Health Aging, Rhythms and Sleep Study

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

Ganaxolone Treatment in Children With Fragile X Syndrome

Pain in Breast Surgery Intervention

Clinical Feasibility of Transcranial Direct Current Stimulation [tDCS] With Standard Aphasia Therapy

Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing

A Framework For Linking Sequential Pattern Rules in DLD: Perception in Toddlers

Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)

Treating Passive Structure Knowledge Deficits in School-Age Children With Developmental Language Disorder

Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

Longitudinal Study of Multiple Symptoms in Advanced Lung Cancer

A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome

Continuous Intercostal Nerve Blockade for Traumatic Rib Fractures